USD 7.04
(0.0%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - |
Cost of Revenue | - | - | - | - | - | - |
Gross Profit | - | - | - | - | - | - |
Operating Expenses | 28.42 Thousand | 36.98 Thousand | 26.04 Thousand | 28.96 Thousand | 26.74 Thousand | 29.68 Thousand |
Selling, General and Administrative Expenses | 28.42 Thousand | 36.98 Thousand | 26.04 Thousand | 28.96 Thousand | 26.74 Thousand | 29.68 Thousand |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | - | - | - | - | - | - |
Cost and Expenses | 28.42 Thousand | 36.98 Thousand | 26.04 Thousand | 28.96 Thousand | 26.74 Thousand | 29.68 Thousand |
Operating Income | -28.43 Thousand | -36.98 Thousand | -26.04 Thousand | -28.96 Thousand | -26.75 Thousand | -29.68 Thousand |
Interest Expense | - | - | - | - | - | - |
Income Tax Expense | -167.89 Thousand | -228.48 Thousand | -236.55 Thousand | -206.29 Thousand | -171.86 Thousand | - |
Earnings before Tax | -28.42 Thousand | -36.98 Thousand | -26.04 Thousand | -28.96 Thousand | -26.74 Thousand | -29.68 Thousand |
Net Income | -28.42 Thousand | -36.98 Thousand | -26.04 Thousand | -28.96 Thousand | -26.74 Thousand | -29.68 Thousand |
Earnings Per Share Basic | -0.00 | -0.00 | -0.01 | -0.01 | -0.01 | -0.00 |
Earnings Per Share Diluted | -0.00 | -0.00 | -0.01 | -0.01 | -0.01 | -0.00 |
Weighted Average Shares Outstanding | 63.5 Million | 9.02 Million | 2.5 Million | 2.5 Million | 2.5 Million | 9.92 Million |
Weighted Average Shares Outstanding (Diluted) | 63.5 Million | 9.02 Million | 2.5 Million | 2.5 Million | 2.5 Million | 9.92 Million |
Gross Margin | - | - | - | - | - | - |
EBIT Margin | - | - | - | - | - | - |
Profit Margin | - | - | - | - | - | - |
EBITDA | -28.43 Thousand | -36.98 Thousand | -26.04 Thousand | -28.96 Thousand | -26.75 Thousand | -29.68 Thousand |
Earnings Before Tax Margin | - | - | - | - | - | - |
Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - |
Cost of Revenue | - | - | - | - | - | - |
Gross Profit | - | - | - | - | - | - |
Operating Expenses | 8417.00 | 5353.00 | 6425.00 | 28.42 Thousand | 8076.00 | 5962.00 |
Selling, General and Administrative Expenses | 8417.00 | 5353.00 | 6425.00 | - | 8076.00 | 5962.00 |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | - | - | - | - | - | - |
Cost and Expenses | 8417.00 | 5353.00 | 6425.00 | 28.42 Thousand | 8076.00 | 5962.00 |
Operating Income | -8417.00 | -5350.00 | -6420.00 | -28.43 Thousand | -8076.00 | -5962.00 |
Interest Expense | - | - | - | - | - | - |
Income Tax Expense | - | - | -43.27 Thousand | -167.89 Thousand | - | 39.58 Thousand |
Earnings before Tax | -8117.00 | -5353.00 | -6425.00 | -28.42 Thousand | -8076.00 | -5962.00 |
Net Income | -8117.00 | -5353.00 | -6425.00 | -28.42 Thousand | -8076.00 | -5962.00 |
Earnings Per Share Basic | -0.00 | -0.00 | -0.00 | - | -0.00 | -0.00 |
Earnings Per Share Diluted | -0.00 | -0.00 | -0.00 | - | -0.00 | -0.00 |
Weighted Average Shares Outstanding | 63.5 Million | 63.5 Million | 63.5 Million | 63.5 Million | 63.5 Million | 63.5 Million |
Weighted Average Shares Outstanding (Diluted) | 63.5 Million | 63.5 Million | 63.5 Million | 63.5 Million | 63.5 Million | 63.5 Million |
Gross Margin | - | - | - | - | - | - |
EBIT Margin | - | - | - | - | - | - |
Profit Margin | - | - | - | - | - | - |
EBITDA | -8417.00 | -5350.00 | -6420.00 | - | -8076.00 | -5962.00 |
Earnings Before Tax Margin | - | - | - | - | - | - |
NATURAL
2453
ADF
IMUC
PSHG
HEAL